Skip to content

Oruka Therapeutics, Inc. ORKA Unrecognized Tax Benefits

Unrecognized Tax Benefits at other companies

Piper Sandler logo
Piper SandlerPIPR
$2.2M+14.8%
Cohen & Steers logo
Cohen & SteersCNS
$546K-58.4%
Mueller Water Products logo
Mueller Water ProductsMWA
$67M+25.5%
Dorman Products logo
Dorman ProductsDORM
$10.5M+1.0%
Bright Horizons Family Solutions logo
Bright Horizons Family SolutionsBFAM
$1.1M
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$0

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$5.03B+533%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefits.

The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s unrecognized tax benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s unrecognized tax benefits?
Oruka Therapeutics, Inc. (ORKA) reported unrecognized tax benefits of $1.82M in Q4 2025.
What does unrecognized tax benefits mean?
This represents the amount of tax benefits from uncertain tax positions that have not been recognized in the financial statements because they do not meet the 'more-likely-than-not' threshold. It reflects the company's exposure to potential tax audits and disputes with tax authorities. This is a key indicator of tax-related legal and financial risk.